¹ 200-16 HepatitEIA-HBsAg Quantitative determination of HBsAg!
The first serological marker detected in patients infected with hepatitis B is the hepatitis B surface antigen (HBsAg), followed by antibodies against viral proteins. HBsAg is detected before onset of disease and increases during disease and eventually, depending on the course of infection, HBsAg levels decline during convalescence. The hepatitis B virus has evolved in 9 immunological subtypes linked to 8 different genotypes (A-H). Depending on geographic region different genotypes/ subtypes are dominantly found. Serological detection of HBsAg by enzyme-linked immunosorbent assays (ELISA) involves the use monoclonal anti-HBs antibodies bound to a solid-phase and second labeled anti-HBs to detect the captured antigen.
The “HepatitIEA-HBsAg” assay is designed for the detection of all dominant HBsAg subtypes using a mixture of monoclonal antibodies to capture HBsAg.
|Kit volume, tests (including controls)||96 (192)|
|Analitical sensitivity, IU/ml||0,05|
|Range of evaluated concentrations, IU/ml||0-5|
|Incubation time, minutes||30+30|
|Incubation temperature, îÑ||37|
|Sample volume, ml||100|
|Expiry date (Shelf-life), month||12|